Secukinumab is the most efficient treatment for achieving clear skin in psoriatic patients: a cost-consequence study from the Spanish National Health Service.
Lluis L PuigJaume NotarioAlberto Jiménez-MoralesDavid Moreno-RamírezAnna López-FerrerIrmina GozalboMíriam PradesLuis LizánCarles BlanchPublished in: The Journal of dermatological treatment (2017)
Secukinumab as first-line biologic treatment is the most efficient treatment for moderate-to-severe plaque psoriasis in the short-to-medium term.